Detection of Ebola Viral Antigen by Enzyme-Linked Immunosorbent Assay Using a Novel Monoclonal Antibody to Nucleoprotein

ABSTRACT With the increase in international traffic, the risk of introducing rare but severe infectious diseases like Ebola hemorrhagic fever is increasing all over the world. However, the system for the diagnosis of Ebola virus infection is available in a limited number of countries. In the present study, we developed an Ebola virus antigen-detection enzyme-linked immunosorbent assay (ELISA) system using a novel monoclonal antibody (MAb) to the nucleoprotein (NP). This antibody recognized an epitope defined by a 26-amino-acid stretch near the C terminus of NP. In a sandwich ELISA system with the MAb, as little as 30 ng of purified recombinant NP (rNP) was detected. Although this MAb was prepared by immunization with rNP of subtype Zaire, it also reacted to the corresponding region of NP derived from the Reston and Sudan subtypes. These results suggest that our ELISA system should work with three of four Ebola subtypes. Furthermore, our ELISA system detected the NP in subtype Reston-infected monkey specimens, while the background level in noninfected specimens was very low, suggesting the usefulness of the ELISA for laboratory diagnosis with clinical specimens.

[1]  C. Boesch,et al.  Isolation and partial characterisation of a new strain of Ebola virus , 1995, The Lancet.

[2]  A. Sanchez,et al.  Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. , 1999, The Journal of infectious diseases.

[3]  P. Jahrling,et al.  Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates , 1992, Journal of clinical microbiology.

[4]  S. Hazar,et al.  Filoviridae: Marburg and Ebola viruses. , 2000 .

[5]  S. R. Zaki,et al.  Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. , 1997, Emerging infectious diseases.

[6]  M. Saijo,et al.  Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Ebola and Marburg Viruses Using Recombinant Nucleoproteins , 2001, Journal of Clinical Microbiology.

[7]  J. Leduc,et al.  An introduction to Ebola: the virus and the disease. , 1999, The Journal of infectious diseases.

[8]  J. McCormick,et al.  The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression. , 1989, Virology.

[9]  L. Hutwagner,et al.  Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain. , 1992, The Journal of infectious diseases.

[10]  A. Sanchez,et al.  Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.

[11]  Y. Matsuura,et al.  Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. , 1987, The Journal of general virology.

[12]  A. Rowe,et al.  Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.

[13]  P. Debré,et al.  Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients , 1999, Nature Medicine.

[14]  S. Dowell,et al.  Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. , 1999, The Journal of infectious diseases.

[15]  M. Saijo,et al.  Immunofluorescence Method for Detection of Ebola Virus Immunoglobulin G, Using HeLa Cells Which Express Recombinant Nucleoprotein , 2001, Journal of Clinical Microbiology.

[16]  H. Feldmann,et al.  Classification, structure, and replication of filoviruses. , 1999, Current topics in microbiology and immunology.

[17]  A. Sanchez,et al.  Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. , 1999, The Journal of infectious diseases.